Completed PHASE3 INTERVENTIONAL 2-arm NCT01554826

Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)

A Double - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion)(0.25ml Formulation for Pediatric Use)

Sponsor: Hualan Biological Engineering, Inc.

Conditions Influenza

Interventions Inactivated Influenza Vaccine Influenza Split Vaccine

Updated 5 times since 2017 Last updated: Sep 4, 2012 Started: Mar 31, 2009 Primary completion: May 31, 2009 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Influenza, this trial is completed. The trial is conducted by Hualan Biological Engineering, Inc. and has accumulated 5 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hualan Biological Engineering, Inc.

Data source: Hualan Biological Engineering, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Huaian, China